Elucidating the exact pharmacological mechanism of motion (MOA) of naturally occurring compounds can be challenging. Whilst Tarselli et al. (60) designed the initial de novo artificial pathway to conolidine and showcased this naturally happening compound correctly suppresses responses to equally chemically induced and inflammation-derived pain, the pharmacologic target to https://isconolidineanopiate43209.ttblogs.com/17693960/conoldine-alternative-natural-pain-relief-no-further-a-mystery